Genetic Analysis of TREM2 Variants in Tunisian Patients with Alzheimer's Disease

Med Princ Pract. 2018;27(4):317-322. doi: 10.1159/000489779. Epub 2018 May 3.

Abstract

Objective: Rare variants in the TREM2 gene have been reported to significantly increase the risk of Alzheimer's disease in Caucasian populations. Hitherto, this association was not studied in North African populations. In this work, we aimed to study the association between TREM2 exon 2 variants and the risk of late-onset Alzheimer's disease (LOAD) in a Tunisian population.

Subjects and methods: We sequenced exon 2 of TREM2 in a Tunisian cohort of 172 LOAD patients and 158 control subjects. We used the Fisher exact test to compare the distribution of allelic frequencies between the two groups.

Results: We identified 4 previously reported nonsynonymous variants (p.Asp39Glu, p.Arg62His, p.Thr96Lys, and p.Val126Gly) and 1 novel synonymous variant (p.Gln109Gln), none of which was significantly associated with the risk of Alzheimer's disease. Moreover, the rare TREM2 variant (p.Arg47His), which was considered to be a risk factor for Alzheimer's disease in European descent populations, was not detected in our cohort.

Conclusion: These findings do not support a major role for TREM2 in the pathogenesis of LOAD in the Tunisian population.

Keywords: Alzheimer’s disease; Case-control study; North-African population; TREM2 gene; Variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Genotyping Techniques
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Receptors, Immunologic / genetics*
  • Risk Factors
  • Sequence Analysis
  • Tunisia
  • White People

Substances

  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TREM2 protein, human